EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination

Elana Ben-Akiva iD, Johan Karlsson iD, Shayan Hemmati, Hongzhe Yu, Stephany Y Tzeng, Drew M Pardoll, Jordan J Green iD

Proceedings of the National Academy of Sciences · 27.06.2023 · 120 (26)

DOI: 10.1073/pnas.2301606120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 20.06.2023. Verfasst von Elana Ben-Akiva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21231. Hauptthemen laut MEDLINE: Cancer Vaccines, Adenocarcinoma, Colonic Neoplasms, Nanoparticles. Die Arbeit wurde bisher 144-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIBIB NIH HHS, HHS | NIH | National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticle (NP)-based mRNA cancer vaccines hold great promise to realize personalized cancer treatments. To advance this technology requires delivery formulations for efficient intracellular delivery to antigen-presenting cells. We developed a class of bioreducible lipophilic poly(beta-amino ester) nanocarriers with quadpolymer architecture. The platform is agnostic to the mRNA sequence, with one-step self-assembly allowing for delivery of multiple antigen-encoding mRNAs as well as codelivery of nucleic acid–based adjuvants. We examined structure–function relationships for NP-mediated mRNA delivery to dendritic cells (DCs) and identified that a lipid subunit of the polymer structure was critical. Following intravenous administration, the engineered NP design facilitated targeted delivery to the spleen and preferential transfection of DCs without the need for surface functionalization with targeting ligands. Treatment with engineered NPs codelivering antigen-encoding mRNA and toll-like receptor agonist adjuvants led to robust antigen-specific CD8+ T cell responses, resulting in efficient antitumor therapy in in vivo models of murine melanoma and colon adenocarcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesAdenocarcinomaColonic NeoplasmsNanoparticlesAnimalsMiceHumansDendritic CellsSpleenLigandsRNA, MessengerAntigensAdjuvants, ImmunologicVaccinationPolymers

Stichwörter der Autor:innen

cancerdeliverymRNAnanoparticlevaccine

Substanzen

Cancer VaccinesLigandsRNA, MessengerAntigensAdjuvants, ImmunologicPolymers

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21231.
  • Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231.
  • Institute for NanoBioTechnology, Johns Hopkins University School of Medicine, Baltimore, MD 21231.
  • Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21287.
  • Department of Chemistry-Ångström Laboratory, Uppsala University, Uppsala SE-75121, Sweden.
  • Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231.

ORCID-Profile: Elana Ben-Akiva, Johan Karlsson, Jordan J Green

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS
  • HHS | NIH | National Cancer Institute
  • HHS | NIH | National Institute of Biomedical Imaging and Bioengineering
  • Goldhirsh-Yellin Foundation

Zitieren

APA

Ben-Akiva, E., Karlsson, J., Hemmati, S., Yu, H., Tzeng, S. Y., Pardoll, D. M., & Green, J. J. (2023). Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination. Proceedings of the National Academy of Sciences, 120(26). https://doi.org/10.1073/pnas.2301606120

Vancouver

Ben-Akiva E, Karlsson J, Hemmati S, Yu H, Tzeng SY, Pardoll DM, et al. Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination. Proceedings of the National Academy of Sciences. 2023;120(26). doi:10.1073/pnas.2301606120

BibTeX
@article{BenAkiva2023,
  author = {Ben-Akiva, Elana and Karlsson, Johan and Hemmati, Shayan and Yu, Hongzhe and Tzeng, Stephany Y and Pardoll, Drew M and Green, Jordan J},
  title = {Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  volume = {120},
  number = {26},
  doi = {10.1073/pnas.2301606120}
}
Kostenlos starten →